Fitness costs limit influenza A virus hemagglutinin glycosylation as an immune evasion strategy.
about
Connecting the study of wild influenza with the potential for pandemic diseaseEvolution of the receptor binding properties of the influenza A(H3N2) hemagglutininStructure and receptor binding preferences of recombinant human A(H3N2) virus hemagglutininsThe M segment of the 2009 pandemic influenza virus confers increased neuraminidase activity, filamentous morphology, and efficient contact transmissibility to A/Puerto Rico/8/1934-based reassortant virusesCompensatory hemagglutinin mutations alter antigenic properties of influenza virusesEpitope specific T-cell responses against influenza A in a healthy population.Playing hide and seek: how glycosylation of the influenza virus hemagglutinin can modulate the immune response to infection.Bird to human transmission biases and vaccine escape mutants in H5N1 infectionsExpansion of genotypic diversity and establishment of 2009 H1N1 pandemic-origin internal genes in pigs in China.Molecular determinants of influenza virus pathogenesis in mice.Amino Acid Substitutions Improve the Immunogenicity of H7N7HA Protein and Protect Mice against Lethal H7N7 Viral Challenge.N-linked glycosylation in the hemagglutinin of influenza A viruses.H5N1 receptor specificity as a factor in pandemic riskGenetic requirement for hemagglutinin glycosylation and its implications for influenza A H1N1 virus evolutionGlycosylations in the globular head of the hemagglutinin protein modulate the virulence and antigenic properties of the H1N1 influenza virusesFitness Inference from Short-Read Data: Within-Host Evolution of a Reassortant H5N1 Influenza VirusCompensatory evolution of net-charge in influenza A virus hemagglutinin.A combination of HA and PA mutations enhances virulence in a mouse-adapted H6N6 influenza A virus.Comparative glycomics analysis of influenza Hemagglutinin (H5N1) produced in vaccine relevant cell platforms.Glycan masking of hemagglutinin for adenovirus vector and recombinant protein immunizations elicits broadly neutralizing antibodies against H5N1 avian influenza viruses.Glycosylation of Residue 141 of Subtype H7 Influenza A Hemagglutinin (HA) Affects HA-Pseudovirus Infectivity and Sensitivity to Site A Neutralizing AntibodiesThe effects of a deleterious mutation load on patterns of influenza A/H3N2's antigenic evolution in humansGlycan-dependent immunogenicity of recombinant soluble trimeric hemagglutinin.Influenza A Virus-Induced Expression of a GalNAc Transferase, GALNT3, via MicroRNAs Is Required for Enhanced Viral Replication.The evolutionary dynamics of receptor binding avidity in influenza A: a mathematical model for a new antigenic drift hypothesis.Defining influenza A virus hemagglutinin antigenic drift by sequential monoclonal antibody selection.Greasing the SCIDs for universal flu antibodiesThe Molecular Determinants of Antibody Recognition and Antigenic Drift in the H3 Hemagglutinin of Swine Influenza A Virus.A mutant influenza virus that uses an N1 neuraminidase as the receptor-binding protein.Integrated Omics and Computational Glycobiology Reveal Structural Basis for Influenza A Virus Glycan Microheterogeneity and Host Interactions.The paramyxovirus polymerase complex as a target for next-generation anti-paramyxovirus therapeutics.Assessing the oseltamivir-induced resistance risk and implications for influenza infection control strategiesBiological roles of glycans.A Perspective on the Structural and Functional Constraints for Immune Evasion: Insights from Influenza Virus.Adaptive mutations of neuraminidase stalk truncation and deglycosylation confer enhanced pathogenicity of influenza A viruses.Expected Effect of Deleterious Mutations on Within-Host Adaptation of Pathogens.Migration of the swine influenza virus δ-cluster hemagglutinin N-linked glycosylation site from N142 to N144 results in loss of antibody cross-reactivity.Guiding the immune response against influenza virus hemagglutinin toward the conserved stalk domain by hyperglycosylation of the globular head domainMolecular characterization of the surface glycoprotein genes of highly pathogenic H5N1 avian influenza viruses detected in Iran in 2011.Antigenicity of the 2015-2016 seasonal H1N1 human influenza virus HA and NA proteins.
P2860
Q27027237-749FDD0E-E3F7-4C59-8176-81CFDD2DD8BBQ27675474-656C9B8D-2056-4E86-B0D1-2DF60175872CQ27697647-7DB4D728-E707-4831-A908-336A49EE982BQ28384333-B800FCB2-6C35-434A-ABAC-9689FD5F15EEQ28390159-DF64A26D-9C75-4196-96FE-EBBA05454829Q30202358-4256FEF8-71CA-43DF-A472-3AE82C5FDC7AQ30360290-6FD60C3A-047D-420E-9B94-4E52B1C90ED6Q30364257-E278E978-46F9-4310-87DC-5485D09D9C5DQ30364522-AA760ACD-799D-43B4-A8B4-831F9E62A065Q30364868-F8550D11-DA37-4A57-B9F8-81F87F816792Q30375164-EFE39285-F8A2-46C0-B606-50566F1EC7A1Q30420126-48D64531-C1B5-4082-9D0C-30BAC4001221Q30429803-D9A99699-E0C8-4180-BD90-F0F5728A495AQ30430014-07ED30C1-F33A-4363-8BAD-F4345848EB77Q30431220-311910C8-E3F7-4475-B098-6E91334A21AFQ30985242-99E06E44-A242-4351-BA54-8C48F22F2EF7Q34342017-A49494E0-AA64-4791-A680-0D2CE0B60384Q34595044-CE4FCF74-8227-40A2-96CB-D32FBC5CA797Q34814833-647C09F4-CABB-43F8-BAD5-90935186BB40Q35132253-68DDDB77-9608-432C-896E-ADF9D52284FDQ35919479-3A158F79-89ED-41DE-AEB3-47376311AD2CQ36177833-426E7196-7B64-402B-8CCE-498F3DA571D8Q36363190-BF91A5C6-D8D9-40E8-BCC3-4C144505164AQ36524003-899D4231-A2F0-4B94-810F-EB16EA22FC92Q36918031-DBF7B0FC-2936-43ED-94B1-8280C7496DF4Q37104756-7DE10355-CD57-4878-8996-2AC9CDA0BB80Q37146934-D68A1550-20C9-4029-ABCF-9D76556A080DQ37224897-C0D61DC8-20DB-4BAA-898E-7B4236938FFEQ37336357-B5FCD248-CBBF-4426-BDF7-50DA29F2102DQ37372252-FD691456-C643-438E-A09D-27BEB467B059Q38510112-D0B1D2F9-38DE-4114-B2F9-0AF1AA3BDF67Q38633113-74CD1EF0-4C6A-45AC-A682-A696830AAD3CQ38936714-0C324CA3-9E58-4394-B770-215075BC8D77Q39397313-5DBD9651-F84D-4611-A75E-8BD04CE74798Q40052151-E7C3D1F7-CE54-4708-B6C7-C66816F35899Q41140967-4FF99ED0-A1F7-4872-8538-CF8B5BAE0D2FQ41812793-A91EA753-1FBA-41FF-BD59-9E22CCAABAD2Q41909093-C0A167A3-2107-4E91-900A-D9F2378373AEQ42245262-AE2D462A-1715-4303-8E15-0B3E032997F4Q45324745-C51A0C00-820D-42B7-AE83-888B21DE79B1
P2860
Fitness costs limit influenza A virus hemagglutinin glycosylation as an immune evasion strategy.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Fitness costs limit influenza ...... as an immune evasion strategy.
@ast
Fitness costs limit influenza ...... as an immune evasion strategy.
@en
type
label
Fitness costs limit influenza ...... as an immune evasion strategy.
@ast
Fitness costs limit influenza ...... as an immune evasion strategy.
@en
prefLabel
Fitness costs limit influenza ...... as an immune evasion strategy.
@ast
Fitness costs limit influenza ...... as an immune evasion strategy.
@en
P2093
P2860
P50
P356
P1476
Fitness costs limit influenza ...... as an immune evasion strategy
@en
P2093
Jack R Bennink
James S Gibbs
Loren Schmidt
Scott E Hensley
William L Ince
P2860
P304
P356
10.1073/PNAS.1108754108
P407
P577
2011-11-21T00:00:00Z